Valeritas Holdings Inc (NASDAQ:VLRX) major shareholder Armistice Capital Master Fund bought 226,000 shares of the stock in a transaction dated Tuesday, May 21st. The shares were bought at an average price of $0.66 per share, for a total transaction of $149,160.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Armistice Capital Master Fund also recently made the following trade(s):
- On Friday, May 10th, Armistice Capital Master Fund bought 100,000 shares of Valeritas stock. The shares were bought at an average price of $0.31 per share, for a total transaction of $31,000.00.
- On Monday, March 25th, Armistice Capital Master Fund bought 50,000 shares of Valeritas stock. The shares were bought at an average price of $0.33 per share, for a total transaction of $16,500.00.
VLRX opened at $2.38 on Friday. Valeritas Holdings Inc has a one year low of $2.10 and a one year high of $41.60. The company has a market capitalization of $20.01 million, a P/E ratio of -0.07 and a beta of 2.00. The company has a debt-to-equity ratio of 29.19, a quick ratio of 2.81 and a current ratio of 3.32.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its holdings in Valeritas by 138.0% in the fourth quarter. Geode Capital Management LLC now owns 186,971 shares of the company’s stock valued at $60,000 after acquiring an additional 108,416 shares during the last quarter. Millennium Management LLC acquired a new position in Valeritas in the fourth quarter valued at approximately $165,000. Weiss Multi Strategy Advisers LLC acquired a new position in Valeritas in the fourth quarter valued at approximately $41,000. CVI Holdings LLC acquired a new position in Valeritas in the fourth quarter valued at approximately $832,000. Finally, Northern Trust Corp lifted its holdings in Valeritas by 855.4% in the fourth quarter. Northern Trust Corp now owns 185,469 shares of the company’s stock valued at $60,000 after acquiring an additional 166,057 shares during the last quarter. Hedge funds and other institutional investors own 34.36% of the company’s stock.
Several brokerages have recently weighed in on VLRX. Zacks Investment Research upgraded Valeritas from a “hold” rating to a “buy” rating and set a $0.50 target price on the stock in a report on Saturday, February 23rd. Oppenheimer set a $2.00 target price on Valeritas and gave the stock a “buy” rating in a report on Friday, May 10th. Finally, ValuEngine cut Valeritas from a “buy” rating to a “hold” rating in a report on Saturday, May 18th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $2.10.
ILLEGAL ACTIVITY WARNING: “Armistice Capital Master Fund Purchases 226,000 Shares of Valeritas Holdings Inc (VLRX) Stock” was first reported by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/24/armistice-capital-master-fund-purchases-226000-shares-of-valeritas-holdings-inc-vlrx-stock.html.
Valeritas Company Profile
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization.
See Also: How do taxes affect a CDs total return?
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.